EOCN · Eocene Ltd.
AI read · Good for EOCN
The AI's read
That gives Eocene a chance to reach more surgeons and patients. The company says the device could reduce the need for diverting stomas, but reports no sales or patient results. Its U.S. pivotal study is still underway, so this adds a sales opportunity without proving demand or success.